Document is current
Any future updates will be listed below
-
Authors
Brauer, Berit K https://orcid.org/0009-0007-6855-5175
Chen, Zilei https://orcid.org/0000-0003-2300-9211
Beirow, Felix https://orcid.org/0009-0006-1223-4594
Li, Jiaran
Meisinger, Daniel
Capriotti, Emanuela
Schweizer, Michaela
Wagner, Lea https://orcid.org/0009-0005-6301-4519
Wienberg, Jascha https://orcid.org/0009-0000-7793-2904
Hobohm, Laura https://orcid.org/0000-0001-6125-7940
Blume, Lukas https://orcid.org/0000-0003-1889-0470
Qiao, Wenjie
Narimatsu, Yoshiki
Carette, Jan E
Clausen, Henrik https://orcid.org/0000-0002-0915-5055
Winter, Dominic https://orcid.org/0000-0001-6788-6641
Braulke, Thomas
Jabs, Sabrina https://orcid.org/0000-0001-8065-8002
Voss, Matthias https://orcid.org/0000-0002-4217-3175
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC877)
Deutsche Forschungsgemeinschaft (FOR2625 TP7)
Deutsche Forschungsgemeinschaft (RTG2771)
Fritz Thyssen Stiftung (n/a)
Christian-Albrechts-Universität zu Kiel (n/a)
China Scholarship Council (n/a)
Novo Nordisk Fonden (NNF24OC0088218)
- License Information
-
More Information
Article History
Received: 6 June 2024
Revised: 17 October 2024
Accepted: 21 October 2024
First Online: 25 November 2024
Disclosure and competing interests statement
: The authors declare no competing interests. YN and HC have a financial interest in GlycoDisplay Aps. HC has a financial interest in GO Therapeutics Inc. YN and HC’s interests are reviewed and managed by the University of Copenhagen in accordance with their conflict of interest policies.
